Botulinum toxin type A promotes microglial M2 polarization and suppresses chronic constriction injury-induced neuropathic pain through the P2X7 receptor

Effects of Betaine on LPS-Stimulated Activation of Microglial M1/M2 Phenotypes by Suppressing TLR4/NF-κB Pathways in N9 Cells

(2019) Hui Shi et al.   MOLECULES

Botulinum Toxin Type A—A Modulator of Spinal Neuron–Glia Interactions under Neuropathic Pain Conditions

(2018) Ewelina Rojewska et al.   Toxins

Inhibition of MyD88 Signaling Skews Microglia/Macrophage Polarization and Attenuates Neuronal Apoptosis in the Hippocampus After Status Epilepticus in Mice

(2018) Jin-Tao Liu et al.   Neurotherapeutics

Pupillary Response to Negative Emotional Stimuli Is Differentially Affected in Meditation Practitioners

(2017) Alejandra Vasquez-Rosati et al.   Frontiers in Human Neuroscience

Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations

(2017) Claire Tronel et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Infant nerve injury induces delayed microglial polarization to the M1 phenotype, and exercise reduces delayed neuropathic pain by modulating microglial activity

(2017) Xingrui Gong et al.   NEUROSCIENCE

Influence of extracellular zinc on M1 microglial activation

(2017) Youichirou Higashi et al.   Scientific Reports

Botulinum toxin type A for neuropathic pain in patients with spinal cord injury

(2016) Zee-A Han et al.   ANNALS OF NEUROLOGY

LncRNA uc.48+ siRNA improved diabetic sympathetic neuropathy in type 2 diabetic rats mediated by P2X7 receptor in SCG

(2016) Bing Wu et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic Pain

(2016) K.Y. Yang et al.   JOURNAL OF DENTAL RESEARCH

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies

(2016) Anna Piotrowska et al.   NEUROPHARMACOLOGY

Antidepressant therapies inhibit inflammation and microglial M1-polarization

(2016) Hans O. Kalkman et al.   PHARMACOLOGY & THERAPEUTICS

LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia

(2016) Shuangmei Liu et al.   Molecular Brain

M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3

(2014) Kavindra Kumara Wijesundera et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Neuropathic pain: mechanisms and their clinical implications

(2014) S. P. Cohen et al.   BMJ-British Medical Journal

Resolvin E1 Inhibits Neuropathic Pain and Spinal Cord Microglial Activation Following Peripheral Nerve Injury

(2012) Zhen-Zhong Xu et al.   Journal of Neuroimmune Pharmacology

MicroRNA-124 as a novel treatment for persistent hyperalgesia

(2012) Hanneke LDM Willemen et al.   Journal of Neuroinflammation

Botulinum Toxin Decreases Hyperalgesia and Inhibits P2X3Receptor Over-Expression in Sensory Neurons Induced by Ventral Root Transection in Rats

(2011) Lizu Xiao et al.   PAIN MEDICINE

Low-dose methotrexate reduces peripheral nerve injury-evoked spinal microglial activation and neuropathic pain behavior in rats

(2008) Joachim Scholz et al.   PAIN